F

Fulcrum Therapeutics

65 employees

We are a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined diseases in areas of high unmet medical need, with an initial focus on rare diseases. Community Guidelines: https://bit.ly/3t2xeR9

Investor insights

Funding rounds participated in

$125M sweet spot round size

Investor type

Privately Held

Basic info

Industry

Biotechnology Research

Sectors

Biotechnology Research

Date founded

2016

Funding rounds raised

Total raised

$125M

from investors over 1 rounds

F

Fulcrum Therapeutics raised $125M on February 17, 2023